A carregar...
Development and validation of a high‐sensitivity assay for measuring p217+tau in plasma
INTRODUCTION: Diagnosis of Alzheimer's disease (AD) based on amyloid beta (A), pathologic tau (T), and neurodegeneration (N) biomarkers in peripheral fluids promises to accelerate clinical trials and intercept disease earlier. METHODS: Qualification of a Simoa plasma p217+tau assay was performe...
Na minha lista:
| Publicado no: | Alzheimers Dement (Amst) |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley and Sons Inc.
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8158165/ https://ncbi.nlm.nih.gov/pubmed/34095436 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/dad2.12204 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|